Elinzanetant Reduces Vasomotor Symptoms of Menopause Across BMI, Smoking Status
Pooled data from the OASIS clinical trial program showed consistent efficacy of elinzanetant across BMI and smoking history subgroups, highlighting its broad applicability.
Atrial Fibrillation in the US 3-Fold More Prevalent Than Previously Estimated, New Data Suggest
Approximately 10.5 million US adults, or 5% of the population, have the atrial fibrillation, according to new prevalence estimates.
Comorbidities Associated with COPD Affect Outcomes, Require Attention
At the 2023 American Thoracic Society International Conference a symposium focused on common comorbidities seen with COPD, their management, and research needs.
